AUTHORS: Zhou, Yang MD et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1588-1597 BACKGROUND: Depressive symptoms occur in over 40% of neurosurgical patients during the perioperative period. However, no measure has been suggested to have a rapid effect on depressive surgical patients during increasingly shorter stays in the hospital. […]
Read MoreAUTHORS: Sequera-Ramos, Luis MD et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1559-1567 BACKGROUND: Beckwith-Wiedemann syndrome (BWS) is the most common congenital overgrowth disorder with an incidence of approximately 1 in 10,000 live births. The condition is characterized by lateralized overgrowth, abdominal wall defects, macroglossia, and predisposition to malignancy. […]
Read MoreAUTHORS: Firth, Paul G. MBChB, BA et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1608-1616 BACKGROUND: The health care systems of low-income countries have severely limited capacity to treat surgical diseases and conditions. There is limited information about which hospital mortality outcomes are suitable metrics in these settings. METHODS: […]
Read MoreAUTHORS: Bravo, Mauro MD et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1532-1539 BACKGROUND: Acetaminophen is commonly used as part of multimodal analgesia for acute pain. The intravenous formulation offers a more predictable bioavailability compared to oral and rectal acetaminophen. There have been reports of hypotension with intravenous acetaminophen […]
Read MoreAUTHORS: Czarnetzki, Christoph MD, MBA et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1540-1549 BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an alternative to succinylcholine for RSI but recovery times are nearly doubled […]
Read More